Roche Holding AG(CH:ROP)
CHF 401.90+0.10 (+0.02%)
CH:ROP
Roche Holding AG stock forecast
CHF 401.90
At close:+0.10 (+0.02%)
Want to see CH:ROP full AI Analyst Report?
Roche Holding AG (ROP) Stock Forecast & Price Target
91 Followers
ROP Analyst Ratings
Moderate Buy
6Buy5Hold1Sell
Based on 12 analysts giving stock ratings to Roche Holding AG in the past 3 months
ROP Stock 12 Month Forecast
Average Price Target
CHF397.54▼(-1.08% Downside)Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF 397.54 with a high forecast of CHF 500.00 and a low forecast of CHF 250.00. The average price target represents a -1.08% change from the last price of CHF 401.90.
Past 12 Months12 Month ForecastJan2026Oct2026
HighCHF500.00
AverageCHF397.54
LowCHF250.00
Highest Price TargetHighestCHF500.00Average Price TargetCHF397.54Lowest Price TargetLowestCHF250.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Graham Parry | Citi | CHF400→CHF440 | buy | 9.48%Upside | Reiterated | 11/09/26 | ||
| Luisa Hector | Berenberg Bank | CHF350 | hold | -12.91%Downside | Reiterated | 11/04/26 | ||
| Matthew Weston | UBS | CHF376→CHF420 | hold | 4.50%Upside | Downgraded | 11/02/26 | ||
| Emmanuel Papadakis | Deutsche Bank | CHF500 | buy | 24.41%Upside | Reiterated | 10/28/26 | ||
| Trung Huynh | RBC Capital | CHF400 | buy | -0.47%Downside | Reiterated | 10/27/26 | ||
| Richard Vosser | J.P. Morgan | CHF325→CHF335 | hold | -16.65%Downside | Reiterated | 10/26/26 | ||
| James Quigley | Goldman Sachs | CHF376→CHF391 | hold | -2.71%Downside | Reiterated | 10/23/26 | ||
| Michael Leuchten | Jefferies | CHF250 | sell | -37.80%Downside | Reiterated | 10/23/26 | ||
 Unknown AnalystNot Ranked | Oddo BHF | CHF300→CHF440 | buy | 9.48%Upside | Upgraded | 10/20/26 | ||
| Justin Smith | Bernstein | CHF434.50 | buy | 8.11%Upside | Reiterated | 10/06/26 | ||
| Rajesh Kumar | HSBC | CHF365→CHF380 | hold | -5.45%Downside | Reiterated | 09/10/26 | ||
| James Gordon CFA | Barclays | CHF410→CHF430 | buy | 6.99%Upside | Reiterated | 09/08/26 | ||
| Hans Engel | Erste Group | ― | hold | ― | Reiterated | 05/04/26 | ||
| Sarita Kapila | Morgan Stanley | CHF295 | hold | -26.60%Downside | Upgraded | 04/24/26 | ||
| David Evans | Kepler Capital | CHF415 | buy | 3.26%Upside | Reiterated | 04/23/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Graham ParryCiti | BuyReiteratedCHF400→CHF440 | 11/09/26 | 9.48%Upside | ||
| Luisa HectorBerenberg Bank | HoldReiteratedCHF350 | 11/04/26 | -12.91%Downside | ||
| Matthew WestonUBS | HoldDowngradedCHF376→CHF420 | 11/02/26 | 4.50%Upside | ||
| Emmanuel PapadakisDeutsche Bank | BuyReiteratedCHF500 | 10/28/26 | 24.41%Upside | ||
| Trung HuynhRBC Capital | BuyReiteratedCHF400 | 10/27/26 | -0.47%Downside | ||
| Richard VosserJ.P. Morgan | HoldReiteratedCHF325→CHF335 | 10/26/26 | -16.65%Downside | ||
| James QuigleyGoldman Sachs | HoldReiteratedCHF376→CHF391 | 10/23/26 | -2.71%Downside | ||
| Michael LeuchtenJefferies | SellReiteratedCHF250 | 10/23/26 | -37.80%Downside | ||
| Unknown AnalystOddo BHFNot Ranked | BuyUpgradedCHF300→CHF440 | 10/20/26 | 9.48%Upside | ||
| Justin SmithBernstein | BuyReiteratedCHF434.50 | 10/06/26 | 8.11%Upside | ||
| Rajesh KumarHSBC | HoldReiteratedCHF365→CHF380 | 09/10/26 | -5.45%Downside | ||
| James Gordon CFABarclays | BuyReiteratedCHF410→CHF430 | 09/08/26 | 6.99%Upside | ||
| Hans EngelErste Group | HoldReiterated | 05/04/26 | ― | ||
| Sarita KapilaMorgan Stanley | HoldUpgradedCHF295 | 04/24/26 | -26.60%Downside | ||
| David EvansKepler Capital | BuyReiteratedCHF415 | 04/23/26 | 3.26%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Roche Holding AG
3 Months
Success Rate15/19 ratings generated profit
79%
Average Return
+8.24%
Copying David Evans's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.24% per trade.
1 Year
Success Rate19/19 ratings generated profit
100%
Average Return
+27.31%
Copying David Evans's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +27.31% per trade.
2 Years
Success Rate19/19 ratings generated profit
100%
Average Return
+50.12%
Copying David Evans's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +50.12% per trade.
ROP Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 2 | 7 | 14 | 15 |
| Hold | 7 | 3 | 7 | 11 | 13 |
| Sell | 3 | 2 | 1 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 7 | 15 | 28 | 31 |
In the current month, ROP has received 15 Buy Ratings, 13 Hold Ratings, and 3 Sell Ratings. ROP average Analyst price target in the past 3 months is 397.54.
ROP Financial Forecast
HighCHF10.48
ConsensusCHF9.70
LowCHF9.10
ROP Earnings Forecast
Next quarter’s earnings estimate for ROP is CHF 9.70 with a range of CHF 9.10 to CHF 10.48. The previous quarter’s EPS was CHF 10.85. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF17.1B
ConsensusCHF16.7B
LowCHF16.4B
ROP Sales Forecast
Next quarter’s sales forecast for ROP is CHF 16.67B with a range of CHF 16.35B to CHF 17.05B. The previous quarter’s sales results were CHF 30.36B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ROP Stock Forecast FAQ
What is CH:ROP’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding AG’s 12-month average price target is CHF397.54.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Roche Holding AG a Buy, Sell or Hold?
Roche Holding AG has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 5 hold ratings and 1 sell ratings.
What is Roche Holding AG’s share price target?
The average share price target for Roche Holding AG is CHF397.54. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF500.00, and the lowest forecast is CHF250.00. The average share price target represents a 1.08% decrease from the current price of CHF401.9.
What do analysts say about Roche Holding AG?
Roche Holding AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of Roche Holding AG?
To buy shares of CH:ROP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
